Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
Clinical trial NCT00005017 · UNKNOWN
Trial details
- NCT number
- NCT00005017
- Sponsor
- Glaxo Wellcome
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.